Anti-HER2 Therapy in Patients of HER2 Positive Metastatic Carcinoma of Digestive System

Conditions:   Targeted Therapy;   HER2;   Biliary Tract Cancer;   Esophageal Squamous Cell Carcinoma
Interventions:   Drug: chemotherapy in combination with trastuzumab;   Drug: chemotherapy in combination with trastuzumab;   Drug: chemotherapy in combination with trastuzumab
Sponsor:   Shen Lin
Not yet recruiting - verified June 2017

http://ift.tt/2sqfx27